11-61362252-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The NM_001161454.1(CYB561A3):c.-749T>C variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0458 in 152,364 control chromosomes in the GnomAD database, including 435 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.046 ( 434 hom., cov: 33)
Exomes 𝑓: 0.050 ( 1 hom. )
Consequence
CYB561A3
NM_001161454.1 5_prime_UTR
NM_001161454.1 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.46
Genes affected
TMEM138 (HGNC:26944): (transmembrane protein 138) This gene encodes a multi-pass transmembrane protein. Reduced expression of this gene in mouse fibroblasts causes short cilia and failure of ciliogenesis. Expression of this gene is tightly coordinated with expression of the neighboring gene TMEM216. Mutations in this gene are associated with the autosomal recessive neurodevelopmental disorder Joubert Syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2012]
CYB561A3 (HGNC:23014): (cytochrome b561 family member A3) Predicted to enable transmembrane ascorbate ferrireductase activity. Predicted to be involved in cellular iron ion homeostasis. Located in nucleolus. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 11-61362252-A-G is Benign according to our data. Variant chr11-61362252-A-G is described in ClinVar as [Likely_benign]. Clinvar id is 305050.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.137 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CYB561A3 | NM_001161454.1 | c.-749T>C | 5_prime_UTR_variant | 1/8 | NP_001154926.1 | |||
CYB561A3 | XM_011544821.3 | c.-749T>C | 5_prime_UTR_variant | 1/8 | XP_011543123.1 | |||
CYB561A3 | XM_047426555.1 | c.-2666T>C | 5_prime_UTR_variant | 1/9 | XP_047282511.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMEM138 | ENST00000542946 | c.-308A>G | 5_prime_UTR_variant | 1/3 | 1 | ENSP00000445792.1 | ||||
CYB561A3 | ENST00000426130.6 | c.-749T>C | 5_prime_UTR_variant | 1/8 | 5 | ENSP00000398979.2 | ||||
TMEM138 | ENST00000692667 | c.-308A>G | 5_prime_UTR_variant | 1/5 | ENSP00000510180.1 |
Frequencies
GnomAD3 genomes AF: 0.0457 AC: 6962AN: 152186Hom.: 428 Cov.: 33
GnomAD3 genomes
AF:
AC:
6962
AN:
152186
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0500 AC: 3AN: 60Hom.: 1 Cov.: 0 AF XY: 0.0455 AC XY: 2AN XY: 44
GnomAD4 exome
AF:
AC:
3
AN:
60
Hom.:
Cov.:
0
AF XY:
AC XY:
2
AN XY:
44
Gnomad4 AFR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
GnomAD4 genome AF: 0.0458 AC: 6980AN: 152304Hom.: 434 Cov.: 33 AF XY: 0.0457 AC XY: 3403AN XY: 74482
GnomAD4 genome
AF:
AC:
6980
AN:
152304
Hom.:
Cov.:
33
AF XY:
AC XY:
3403
AN XY:
74482
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
131
AN:
3478
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Familial aplasia of the vermis Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at